EUVIMEDEUVIMED entdecken
Crossref

Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits

Lauren A Peterson, Christina M Andrews, Amanda J Abraham, Melissa A Westlake, Colleen M Grogan

Health Affairs · 2024

DOI: 10.1377/hlthaff.2023.01023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Lauren A Peterson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lauren A. Peterson (lapeterson@uchicago.edu), University of Chicago, Chicago, Illinois. Hauptthemen laut MEDLINE: Managed Care Programs, Medicaid, Substance-Related Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: NIDA NIH HHS, AHRQ HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Managed care plans, which contract with states to cover three-quarters of Medicaid enrollees, play a crucial role in addressing the drug epidemic in the United States. However, substance use disorder benefits vary across Medicaid managed care plans, and it is unclear what role states play in regulating their activities. To address this question, we surveyed thirty-three states and Washington, D.C., regarding their substance use disorder treatment coverage and utilization management requirements for Medicaid managed care plans in 2021. Most states mandated coverage of common forms of substance use disorder treatment and prohibited annual maximums and enrollee cost sharing in managed care. Fewer than one-third of states forbade managed care plans from imposing prior authorization for each treatment service. For most treatment medications, fewer than two-thirds of states prohibited prior authorization, drug testing, "fail first," or psychosocial therapy requirements in managed care. Our findings suggest that many states give managed care plans broad discretion to impose requirements on covered substance use disorder treatments, which may affect access to lifesaving care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Managed Care ProgramsMedicaidSubstance-Related DisordersUnited StatesHumansInsurance CoverageCost SharingPrior Authorization

Autor:innen und Institutionen

  • Lauren A. Peterson (lapeterson@uchicago.edu), University of Chicago, Chicago, Illinois.
  • Christina M. Andrews, University of South Carolina, Columbia, South Carolina.
  • Amanda J. Abraham, University of Georgia, Athens, Georgia.
  • Melissa A. Westlake, University of South Carolina.
  • Colleen M. Grogan, University of Chicago.

Förderung

  • NIDA NIH HHS
  • AHRQ HHS
  • NIAAA NIH HHS

Zitieren

APA

Peterson, L. A., Andrews, C. M., Abraham, A. J., Westlake, M. A., & Grogan, C. M. (2024). Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits. Health Affairs. https://doi.org/10.1377/hlthaff.2023.01023

Vancouver

Peterson LA, Andrews CM, Abraham AJ, Westlake MA, Grogan CM. Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits. Health Affairs. 2024. doi:10.1377/hlthaff.2023.01023

BibTeX
@article{Peterson2024,
  author = {Peterson, Lauren A and Andrews, Christina M and Abraham, Amanda J and Westlake, Melissa A and Grogan, Colleen M},
  title = {Most States Allow Medicaid Managed Care Plans Discretion To Restrict Substance Use Disorder Treatment Benefits},
  journal = {Health Affairs},
  year = {2024},
  doi = {10.1377/hlthaff.2023.01023}
}
Kostenlos starten →